Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNT-A for erectile dysfunction resistant to PDE5 inhibitors
IRCT20100817004582N10Phase 3Completed
- Sponsor
- Urology Research Centre
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in erectile dysfunction (ED), sponsored by Urology Research Centre. Started Oct 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on IRCT20100817004582N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100817004582N10.